Computerized Thermal Imaging, a thermal breast imaging technology developer, has been notified by the U.S. Food and Drug Administration that its BCS 2100 breast imaging system is scheduled for a 2002 October review by a radiological devices panel. The panel will discuss and make recommendations regarding the Lake Oswego, OR-based manufacturer’s pre-market approval application for the product.
In other news, the company said a peer-reviewed article about the BCS 2100 clinical trials has been accepted for publication in the American Journal of Roentgenology. The article is slated to appear in the January 2003 issue.
By AuntMinnie.com staff writersJuly 25, 2002
Related Reading
CTI faces shareholder lawsuits, May 15, 2002
CTI to receive $22.5 million in financing, December 21, 2001
CTI begins in-house manufacturing, August 15, 2001
CTI signs on four distributors, August 9, 2001
CTI secures CE Mark, June 20, 2001
Copyright © 2002 AuntMinnie.com
